D&d Pharmatech

Developer of GLP-1-based therapeutics for metabolic disease treatment

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2014 groups16 employees language ddpharmatech.com

Registered entities

Innovation

17 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady.

Coming soon